Ergoteles’s uniQure QURE Stock Holding History

Ergoteles’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-61,589	Closed	-$706K	–	653
2023 Q2	$706K	Buy	61,589 +25,985	+73%	+$492K	0.03%	560
2023 Q1	$717K	Buy	+35,604	New	+$747K	0.03%	614
2022 Q3	–	Sell	-22,400	Closed	-$418K	–	1904
2022 Q2	$418K	Buy	+22,400	New	+$356K	0.01%	918

Other funds holding QURE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ergoteles's QURE Position: Q3 2023 in Review

Ergoteles sold out of uniQure (QURE) in Q3 2023, closing a stake of 61,589 shares — an estimated $706K sold.

Ergoteles first reported a position in QURE in Q2 2022 and held it in 3 quarters. The position peaked at $717K in Q1 2023. 159 funds tracked by Wall St. Rank hold QURE as of Q3 2023.

Ergoteles reported no remaining uniQure position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 61,589 uniQure shares in Q3 2023, an estimated $706K.
Ergoteles first reported a position in uniQure in Q2 2022 and held it in 3 quarters.
Ergoteles's uniQure position peaked at $717K in Q1 2023.
159 funds tracked by Wall St. Rank held uniQure as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.